As of Feb 26th, 2025, there has been substantial selling of Tarsus Pharmaceuticals, Inc. in recent trading

The chart below shows ALL of the short selling each day in TARSUS PHARMACEUTICALS, INC. (TARS). We have consolidated the tape of ALL US stock exchanges and dark pools (this means we get the TRADE IDENTIFIER showing whether the trade was a buy, sell or sell short). The data below shows just the short sales each day in your stock. It includes both EXEMPT (market makers) and NON-EXEMPT (everyone else) short sales in TARSUS PHARMACEUTICALS, INC.. An average of 41.57% of the daily trading in TARS is short selling. This is abnormally high and implies there is illicit trading taking place in your stock. We run automated surveillance and reporting algorithms that report manipulative market making and short selling (to FINRA, SEC, Whistleblower's Office and Dept of Treasury FINCEN). We then issue FINRA COMPLIANT research to our large user base to counteract this activity that is driving TARS lower unfairly.

You can find the full report at [ https://www.woprai.com/ ]

Please find the applicable data below, drawn from all major market providers.

Date	Short Volume	Total Volume	Percentage	Squeeze Trigger	$ Value
2025-02-25	756,457	1,781,699	42.46	42.7	32,300,714
2025-02-24	342,130	921,963	37.11	46.48	15,902,202
2025-02-21	161,238	465,242	34.66	48.03	7,744,261
2025-02-20	172,934	434,841	39.77	48.88	8,453,014
2025-02-19	190,698	431,713	44.17	49.82	9,500,574
2025-02-18	196,659	490,966	40.06	50.77	9,984,377
2025-02-14	146,239	303,501	48.18	50.65	7,407,005
2025-02-13	159,874	439,484	36.38	51.94	8,303,856
2025-02-12	227,990	460,900	49.47	51.95	11,844,081
2025-02-11	188,216	515,071	36.54	51.33	9,661,127
2025-02-10	169,613	543,579	31.2	51.82	8,789,346
2025-02-07	252,721	620,699	40.72	52.45	13,255,216
2025-02-06	291,988	587,235	49.72	54.58	15,936,705
2025-02-05	152,166	421,145	36.13	56.77	8,638,464
2025-02-04	135,560	310,315	43.68	54.71	7,416,488
2025-02-03	175,519	399,703	43.91	54.42	9,551,744
2025-01-31	179,591	372,733	48.18	53.52	9,611,710
2025-01-30	318,686	508,671	62.65	52.26	16,654,530
2025-01-29	165,931	366,704	45.25	52.58	8,724,652
2025-01-28	179,046	328,447	54.51	50.99	9,129,556
2025-01-27	333,902	700,579	47.66	51.79	17,292,785
2025-01-24	177,603	433,856	40.94	49.13	8,725,635
2025-01-23	245,700	572,765	42.9	49.11	12,066,327
2025-01-22	248,784	448,491	55.47	47.88	11,911,778
2025-01-21	278,850	537,795	51.85	46.6	12,994,410
2025-01-17	158,028	357,646	44.19	46.66	7,373,586
2025-01-16	163,064	430,605	37.87	46.65	7,606,936
2025-01-15	400,941	869,958	46.09	45.54	18,258,853
2025-01-14	269,455	1,059,939	25.42	44.83	12,079,668
2025-01-13	460,803	1,224,357	37.64	47.65	21,957,263
2025-01-10	474,365	807,572	58.74	52.72	25,008,523
2025-01-08	518,596	872,557	59.43	55.21	28,631,685
2025-01-07	440,569	890,667	49.47	54.55	24,033,039
2025-01-06	434,350	1,487,574	29.2	56.13	24,380,066
2025-01-03	315,521	584,190	54.01	55.39	17,476,708
2025-01-02	324,271	833,604	38.9	55.53	18,006,769
2024-12-31	441,066	742,023	59.44	55.33	24,404,182

Total	124,924,218	298,708,411	41.82	29.17	3,643,495,709

* Totals include all data records back to 2020-10-20 00:00:00, data set is truncated for viewing.

N@N

As of Feb 26th, 2025, there has been substantial selling of Tarsus Pharmaceuticals, Inc. in recent trading